Anne-Cécile Brunac

6PUBLICATIONS
20CO-AUTHORS
Cancer diagnosisLiquid biopsiesHaematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
TOP2 and NOS2 Orchestrate the Generation of DNA Breaks to Promote Colitis Cancer Initiation.

|Mar 11, 2026
A deceptively benign biliary lesion revealing an ALK-rearranged intrahepatic cholangiocarcinoma.

Anne-Cécile Brunac, Marie Danjoux, Hadrien Reboul

|May 30, 2024
Choriocarcinoma in neonates and infants: A severe but curable disease.

Marie Pierre Castex, Joanna Stefanowicz, Laura Clement

|Oct 06, 2022
CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II-III colorectal carcinoma.

Anne-Cécile Brunac, Joanna Fourquet, Gaëlle Perot

|Nov 26, 2020
EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast Cancers.

Mélanie K Prodhomme, Roxane M Pommier, Camille Franchet

|Jan 23, 2020
The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript.

Anne-Cécile Brunac, Anne Laprie, Marie-Pierre Castex

Pageof 1

Frequent Collaborators

2 joint publications

Pierre Brousset

1 joint publications

Joanna Stefanowicz

1 joint publications

Brice Fresneau

1 joint publications

Danuta Januszkiewicz-Lewandowska